NIH Research Illuminates Genetic Basis of Rare Inherited Retinal Diseases
For individuals and families navigating the complexities of inherited retinal diseases (IRDs), new research from the National Institutes of Health (NIH) offers a significant step forward in understanding the genetic underpinnings of these conditions. The identification of genes responsible for certain IRDs is crucial, as it paves the way for improved diagnostics, genetic testing, and ultimately, the development of targeted therapies for vision preservation and restoration within the IRD community.
NIH scientists and their colleagues have identified a gene, UBAP1L, responsible for some inherited retinal diseases. These diseases are a group of disorders that damage the eye's light-sensing retina and threaten vision. Although IRDs collectively affect over 2 million people worldwide, each individual disease is rare, which can complicate efforts to gather sufficient patient populations for study and clinical trials.
In a small study involving six unrelated participants, researchers linked the UBAP1L gene to various forms of retinal dystrophies. These included maculopathy, which affects central vision; cone dystrophy, impacting color vision; and cone-rod dystrophy, which also affects night vision. Patients in the study began experiencing symptoms of retinal dystrophy in early adulthood, with severe vision loss progressing by late adulthood. Genetic evaluation of these six patients revealed four variants in the UBAP1L gene, which is known to encode a protein abundantly expressed in retinal cells, including retinal pigment epithelium cells and photoreceptors.
This discovery holds profound implications for patients and their families. Identifying the specific gene responsible for these forms of IRD means that genetic testing can become more precise, offering clearer diagnoses and prognoses. As Dr. Bin Guan, chief of the Ophthalmic Genomics Laboratory at NIH's National Eye Institute (NEI) and a senior author of the report, stated,